Trial Profile
A phase I trial of natural killer cell therapy in combination with rituximab to treat B-cell malignant lymphoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy (Primary)
- Indications B-cell lymphoma
- Focus Adverse reactions
- 02 Mar 2016 New trial record